14 नवंबर 2026
FDA PDUFA target action date for ivonescimab + chemotherapy, a BLA from Summit Therapeutics. This is the date by which the FDA is due to act on the application; it can be extended or the decision can come earlier.
FDA PDUFA निर्णय तारीखें कैलेंडर